Mill Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.2M | Buy |
79,513
+484
| +0.6% | +$196K | 2.53% | 13 |
|
|
2025
Q1 | $39.3M | Buy |
79,029
+251
| +0.3% | +$125K | 3.15% | 9 |
|
|
2024
Q4 | $41M | Buy |
78,778
+74
| +0.1% | +$38.5K | 3.24% | 8 |
|
|
2024
Q3 | $48.7M | Buy |
78,704
+444
| +0.6% | +$275K | 3.81% | 6 |
|
|
2024
Q2 | $43.3M | Buy |
78,260
+1,151
| +1% | +$637K | 3.57% | 6 |
|
|
2024
Q1 | $44.8M | Buy |
77,109
+298
| +0.4% | +$173K | 3.74% | 6 |
|
|
2023
Q4 | $40.8M | Buy |
76,811
+255
| +0.3% | +$135K | 3.64% | 6 |
|
|
2023
Q3 | $38.8M | Sell |
76,556
-41
| -0.1% | -$20.8K | 3.79% | 6 |
|
|
2023
Q2 | $40M | Sell |
76,597
-164
| -0.2% | -$85.6K | 3.76% | 6 |
|
|
2023
Q1 | $44.2M | Sell |
76,761
-9,701
| -11% | -$5.59M | 4.49% | 5 |
|
|
2022
Q4 | $47.6M | Buy |
86,462
+274
| +0.3% | +$151K | 5.23% | 4 |
|
|
2022
Q3 | $43.7M | Buy |
86,188
+368
| +0.4% | +$187K | 5.1% | 4 |
|
|
2022
Q2 | $46.6M | Sell |
85,820
-1,110
| -1% | -$603K | 5.16% | 4 |
|
|
2022
Q1 | $51.3M | Buy |
86,930
+8,975
| +12% | +$5.3M | 4.91% | 5 |
|
|
2021
Q4 | $52M | Buy |
+77,955
| New | +$52M | 5.33% | 5 |
|